APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ponatinib

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ponatinib Market Analysis and Forecast 2026-2032

22 December 2025196 pages

Choose your research edition.

Industry ResearchPonatinib Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Ponatinib Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Ponatinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ponatinib Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Ponatinib Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Ponatinib market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ponatinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ponatinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ponatinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ponatinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Ponatinib include ARIAD Pharmaceuticals. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ponatinib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ponatinib, also provides the sales of main regions and countries. Of the upcoming market potential for Ponatinib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ponatinib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ponatinib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ponatinib sales, projected growth trends, production technology, application and end-user industry.

Ponatinib Segment by Company

ARIAD Pharmaceuticals

Ponatinib Segment by Type

15mg

45mg

Ponatinib Segment by Application

ALL

CML

Ponatinib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ponatinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ponatinib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ponatinib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Ponatinib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Ponatinib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ponatinib sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ponatinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 15mg Major Manufacturers Table 3. 45mg Major Manufacturers Table 4. Global Ponatinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. ALL Major Manufacturers Table 6. CML Major Manufacturers Table 7. Ponatinib Industry Trends Table 8. Ponatinib Industry Drivers Table 9. Ponatinib Industry Opportunities and Challenges Table 10. Ponatinib Industry Restraints Table 11. Global Ponatinib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Ponatinib Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Ponatinib Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Ponatinib Revenue Market Share by Region (2021-2026) Table 15. Global Ponatinib Revenue Market Share by Region (2027-2032) Table 16. Global Ponatinib Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Ponatinib Sales by Region (2021-2026) & (k units) Table 18. Global Ponatinib Sales by Region (2027-2032) & (k units) Table 19. Global Ponatinib Sales Market Share by Region (2021-2026) Table 20. Global Ponatinib Sales Market Share by Region (2027-2032) Table 21. Global Ponatinib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Ponatinib Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Ponatinib Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Ponatinib Sales Market Share by Manufacturers (2021-2026) Table 25. Global Ponatinib Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Ponatinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Ponatinib Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Ponatinib Manufacturers, Product Type & Application Table 29. Global Ponatinib Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Ponatinib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Ponatinib Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Ponatinib Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Ponatinib Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Ponatinib Revenue Market Share by Type (2021-2026) Table 36. Global Ponatinib Revenue Market Share by Type (2027-2032) Table 37. Global Ponatinib Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Ponatinib Sales by Type (2021-2026) & (k units) Table 39. Global Ponatinib Sales by Type (2027-2032) & (k units) Table 40. Global Ponatinib Sales Market Share by Type (2021-2026) Table 41. Global Ponatinib Sales Market Share by Type (2027-2032) Table 42. Global Ponatinib Price by Type (2021-2026) & (US$/unit) Table 43. Global Ponatinib Price by Type (2027-2032) & (US$/unit) Table 44. Global Ponatinib Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Ponatinib Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Ponatinib Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Ponatinib Revenue Market Share by Application (2021-2026) Table 48. Global Ponatinib Revenue Market Share by Application (2027-2032) Table 49. Global Ponatinib Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Ponatinib Sales by Application (2021-2026) & (k units) Table 51. Global Ponatinib Sales by Application (2027-2032) & (k units) Table 52. Global Ponatinib Sales Market Share by Application (2021-2026) Table 53. Global Ponatinib Sales Market Share by Application (2027-2032) Table 54. Global Ponatinib Price by Application (2021-2026) & (US$/unit) Table 55. Global Ponatinib Price by Application (2027-2032) & (US$/unit) Table 56. ARIAD Pharmaceuticals Company Information Table 57. ARIAD Pharmaceuticals Business Overview Table 58. ARIAD Pharmaceuticals Ponatinib Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. ARIAD Pharmaceuticals Ponatinib Product Portfolio Table 60. ARIAD Pharmaceuticals Recent Development Table 61. North America Ponatinib Revenue by Type (2021-2026) & (US$ Million) Table 62. North America Ponatinib Revenue by Type (2027-2032) & (US$ Million) Table 63. North America Ponatinib Sales by Type (2021-2026) & (k units) Table 64. North America Ponatinib Sales by Type (2027-2032) & (k units) Table 65. North America Ponatinib Sales Price by Type (2021-2026) & (US$/unit) Table 66. North America Ponatinib Sales Price by Type (2027-2032) & (US$/unit) Table 67. North America Ponatinib Revenue by Application (2021-2026) & (US$ Million) Table 68. North America Ponatinib Revenue by Application (2027-2032) & (US$ Million) Table 69. North America Ponatinib Sales by Application (2021-2026) & (k units) Table 70. North America Ponatinib Sales by Application (2027-2032) & (k units) Table 71. North America Ponatinib Sales Price by Application (2021-2026) & (US$/unit) Table 72. North America Ponatinib Sales Price by Application (2027-2032) & (US$/unit) Table 73. North America Ponatinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America Ponatinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 75. North America Ponatinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 76. North America Ponatinib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 77. North America Ponatinib Sales by Country (2021-2026) & (k units) Table 78. North America Ponatinib Sales by Country (2027-2032) & (k units) Table 79. North America Ponatinib Sales Price by Country (2021-2026) & (US$/unit) Table 80. North America Ponatinib Sales Price by Country (2027-2032) & (US$/unit) Table 81. United States Ponatinib Revenue (2021-2032) & (US$ Million) Table 82. Canada Ponatinib Revenue (2021-2032) & (US$ Million) Table 83. Mexico Ponatinib Revenue (2021-2032) & (US$ Million) Table 84. Europe Ponatinib Revenue by Type (2021-2026) & (US$ Million) Table 85. Europe Ponatinib Revenue by Type (2027-2032) & (US$ Million) Table 86. Europe Ponatinib Sales by Type (2021-2026) & (k units) Table 87. Europe Ponatinib Sales by Type (2027-2032) & (k units) Table 88. Europe Ponatinib Sales Price by Type (2021-2026) & (US$/unit) Table 89. Europe Ponatinib Sales Price by Type (2027-2032) & (US$/unit) Table 90. Europe Ponatinib Revenue by Application (2021-2026) & (US$ Million) Table 91. Europe Ponatinib Revenue by Application (2027-2032) & (US$ Million) Table 92. Europe Ponatinib Sales by Application (2021-2026) & (k units) Table 93. Europe Ponatinib Sales by Application (2027-2032) & (k units) Table 94. Europe Ponatinib Sales Price by Application (2021-2026) & (US$/unit) Table 95. Europe Ponatinib Sales Price by Application (2027-2032) & (US$/unit) Table 96. Europe Ponatinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Ponatinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 98. Europe Ponatinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 99. Europe Ponatinib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 100. Europe Ponatinib Sales by Country (2021-2026) & (k units) Table 101. Europe Ponatinib Sales by Country (2027-2032) & (k units) Table 102. Europe Ponatinib Sales Price by Country (2021-2026) & (US$/unit) Table 103. Europe Ponatinib Sales Price by Country (2027-2032) & (US$/unit) Table 104. Germany Ponatinib Revenue (2021-2032) & (US$ Million) Table 105. France Ponatinib Revenue (2021-2032) & (US$ Million) Table 106. U.K. Ponatinib Revenue (2021-2032) & (US$ Million) Table 107. Italy Ponatinib Revenue (2021-2032) & (US$ Million) Table 108. Russia Ponatinib Revenue (2021-2032) & (US$ Million) Table 109. Spain Ponatinib Revenue (2021-2032) & (US$ Million) Table 110. Netherlands Ponatinib Revenue (2021-2032) & (US$ Million) Table 111. Switzerland Ponatinib Revenue (2021-2032) & (US$ Million) Table 112. Sweden Ponatinib Revenue (2021-2032) & (US$ Million) Table 113. Poland Ponatinib Revenue (2021-2032) & (US$ Million) Table 114. China Ponatinib Revenue by Type (2021-2026) & (US$ Million) Table 115. China Ponatinib Revenue by Type (2027-2032) & (US$ Million) Table 116. China Ponatinib Sales by Type (2021-2026) & (k units) Table 117. China Ponatinib Sales by Type (2027-2032) & (k units) Table 118. China Ponatinib Sales Price by Type (2021-2026) & (US$/unit) Table 119. China Ponatinib Sales Price by Type (2027-2032) & (US$/unit) Table 120. China Ponatinib Revenue by Application (2021-2026) & (US$ Million) Table 121. China Ponatinib Revenue by Application (2027-2032) & (US$ Million) Table 122. China Ponatinib Sales by Application (2021-2026) & (k units) Table 123. China Ponatinib Sales by Application (2027-2032) & (k units) Table 124. China Ponatinib Sales Price by Application (2021-2026) & (US$/unit) Table 125. China Ponatinib Sales Price by Application (2027-2032) & (US$/unit) Table 126. Asia Ponatinib Revenue by Type (2021-2026) & (US$ Million) Table 127. Asia Ponatinib Revenue by Type (2027-2032) & (US$ Million) Table 128. Asia Ponatinib Sales by Type (2021-2026) & (k units) Table 129. Asia Ponatinib Sales by Type (2027-2032) & (k units) Table 130. Asia Ponatinib Sales Price by Type (2021-2026) & (US$/unit) Table 131. Asia Ponatinib Sales Price by Type (2027-2032) & (US$/unit) Table 132. Asia Ponatinib Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia Ponatinib Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Ponatinib Sales by Application (2021-2026) & (k units) Table 135. Asia Ponatinib Sales by Application (2027-2032) & (k units) Table 136. Asia Ponatinib Sales Price by Application (2021-2026) & (US$/unit) Table 137. Asia Ponatinib Sales Price by Application (2027-2032) & (US$/unit) Table 138. Asia Ponatinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Asia Ponatinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Asia Ponatinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Asia Ponatinib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 142. Asia Ponatinib Sales by Country (2021-2026) & (k units) Table 143. Asia Ponatinib Sales by Country (2027-2032) & (k units) Table 144. Asia Ponatinib Sales Price by Country (2021-2026) & (US$/unit) Table 145. Asia Ponatinib Sales Price by Country (2027-2032) & (US$/unit) Table 146. Japan Ponatinib Revenue (2021-2032) & (US$ Million) Table 147. South Korea Ponatinib Revenue (2021-2032) & (US$ Million) Table 148. India Ponatinib Revenue (2021-2032) & (US$ Million) Table 149. Australia Ponatinib Revenue (2021-2032) & (US$ Million) Table 150. Taiwan Ponatinib Revenue (2021-2032) & (US$ Million) Table 151. Southeast Asia Ponatinib Revenue (2021-2032) & (US$ Million) Table 152. SAMEA Ponatinib Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA Ponatinib Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA Ponatinib Sales by Type (2021-2026) & (k units) Table 155. SAMEA Ponatinib Sales by Type (2027-2032) & (k units) Table 156. SAMEA Ponatinib Sales Price by Type (2021-2026) & (US$/unit) Table 157. SAMEA Ponatinib Sales Price by Type (2027-2032) & (US$/unit) Table 158. SAMEA Ponatinib Revenue by Application (2021-2026) & (US$ Million) Table 159. SAMEA Ponatinib Revenue by Application (2027-2032) & (US$ Million) Table 160. SAMEA Ponatinib Sales by Application (2021-2026) & (k units) Table 161. SAMEA Ponatinib Sales by Application (2027-2032) & (k units) Table 162. SAMEA Ponatinib Sales Price by Application (2021-2026) & (US$/unit) Table 163. SAMEA Ponatinib Sales Price by Application (2027-2032) & (US$/unit) Table 164. SAMEA Ponatinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. SAMEA Ponatinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. SAMEA Ponatinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. SAMEA Ponatinib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 168. SAMEA Ponatinib Sales by Country (2021-2026) & (k units) Table 169. SAMEA Ponatinib Sales by Country (2027-2032) & (k units) Table 170. SAMEA Ponatinib Sales Price by Country (2021-2026) & (US$/unit) Table 171. SAMEA Ponatinib Sales Price by Country (2027-2032) & (US$/unit) Table 172. Brazil Ponatinib Revenue (2021-2032) & (US$ Million) Table 173. Argentina Ponatinib Revenue (2021-2032) & (US$ Million) Table 174. Chile Ponatinib Revenue (2021-2032) & (US$ Million) Table 175. Colombia Ponatinib Revenue (2021-2032) & (US$ Million) Table 176. Peru Ponatinib Revenue (2021-2032) & (US$ Million) Table 177. Saudi Arabia Ponatinib Revenue (2021-2032) & (US$ Million) Table 178. Israel Ponatinib Revenue (2021-2032) & (US$ Million) Table 179. UAE Ponatinib Revenue (2021-2032) & (US$ Million) Table 180. Turkey Ponatinib Revenue (2021-2032) & (US$ Million) Table 181. Iran Ponatinib Revenue (2021-2032) & (US$ Million) Table 182. Egypt Ponatinib Revenue (2021-2032) & (US$ Million) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Ponatinib Distributors List Table 186. Ponatinib Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Ponatinib Image Figure 2. Global Ponatinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ponatinib Market Size Share 2021 VS 2025 VS 2032 Figure 4. 15mg Image Figure 5. 45mg Image Figure 6. Global Ponatinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Ponatinib Market Size Share 2021 VS 2025 VS 2032 Figure 8. ALL Image Figure 9. CML Image Figure 10. Global Ponatinib Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Ponatinib Revenue (2021-2032) & (US$ Million) Figure 12. Global Ponatinib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Ponatinib Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Ponatinib Revenue Market Share by Region (2021-2032) Figure 15. Global Ponatinib Sales (2021-2032) & (k units) Figure 16. Global Ponatinib Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Ponatinib Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Ponatinib Sales YoY (2021-2032) & (k units) Figure 19. Europe Ponatinib Sales YoY (2021-2032) & (k units) Figure 20. China Ponatinib Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Ponatinib Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Ponatinib Sales YoY (2021-2032) & (k units) Figure 23. Global Ponatinib Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Ponatinib Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Ponatinib Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Ponatinib Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Ponatinib Revenue Market Share by Type (2021-2032) Figure 29. Global Ponatinib Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Ponatinib Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Ponatinib Sales Market Share by Type (2021-2032) Figure 32. Global Ponatinib Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Ponatinib Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Ponatinib Revenue Market Share by Application (2021-2032) Figure 35. Global Ponatinib Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Ponatinib Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Ponatinib Sales Market Share by Application (2021-2032) Figure 38. North America Ponatinib Revenue Share by Type (2021-2032) Figure 39. North America Ponatinib Sales Share by Type (2021-2032) Figure 40. North America Ponatinib Revenue Share by Application (2021-2032) Figure 41. North America Ponatinib Sales Share by Application (2021-2032) Figure 42. North America Ponatinib Revenue Share by Country (2021-2032) Figure 43. North America Ponatinib Sales Share by Country (2021-2032) Figure 44. Europe Ponatinib Revenue Share by Type (2021-2032) Figure 45. Europe Ponatinib Sales Share by Type (2021-2032) Figure 46. Europe Ponatinib Revenue Share by Application (2021-2032) Figure 47. Europe Ponatinib Sales Share by Application (2021-2032) Figure 48. Europe Ponatinib Revenue Share by Country (2021-2032) Figure 49. Europe Ponatinib Sales Share by Country (2021-2032) Figure 50. China Ponatinib Revenue Share by Type (2021-2032) Figure 51. China Ponatinib Sales Share by Type (2021-2032) Figure 52. China Ponatinib Revenue Share by Application (2021-2032) Figure 53. China Ponatinib Sales Share by Application (2021-2032) Figure 54. Asia Ponatinib Revenue Share by Type (2021-2032) Figure 55. Asia Ponatinib Sales Share by Type (2021-2032) Figure 56. Asia Ponatinib Revenue Share by Application (2021-2032) Figure 57. Asia Ponatinib Sales Share by Application (2021-2032) Figure 58. Asia Ponatinib Revenue Share by Country (2021-2032) Figure 59. Asia Ponatinib Sales Share by Country (2021-2032) Figure 60. SAMEA Ponatinib Revenue Share by Type (2021-2032) Figure 61. SAMEA Ponatinib Sales Share by Type (2021-2032) Figure 62. SAMEA Ponatinib Revenue Share by Application (2021-2032) Figure 63. SAMEA Ponatinib Sales Share by Application (2021-2032) Figure 64. SAMEA Ponatinib Revenue Share by Country (2021-2032) Figure 65. SAMEA Ponatinib Sales Share by Country (2021-2032) Figure 66. Ponatinib Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Ponatinib Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 15mg
  • 45mg
Applications
  • ALL
  • CML
Companies covered
  • ARIAD Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ponatinib Market by Type
  3. 1.2.1 Global Ponatinib Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 15mg
  5. 1.2.3 45mg
  6. 1.3 Ponatinib Market by Application
  7. 1.3.1 Global Ponatinib Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 ALL
  9. 1.3.3 CML
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Ponatinib Market Dynamics
  1. 2.1 Ponatinib Industry Trends
  2. 2.2 Ponatinib Industry Drivers
  3. 2.3 Ponatinib Industry Opportunities and Challenges
  4. 2.4 Ponatinib Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Ponatinib Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Ponatinib Revenue by Region
  3. 3.2.1 Global Ponatinib Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ponatinib Revenue by Region (2021-2026)
  5. 3.2.3 Global Ponatinib Revenue by Region (2027-2032)
  6. 3.2.4 Global Ponatinib Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Ponatinib Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Ponatinib Sales by Region
  9. 3.4.1 Global Ponatinib Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Ponatinib Sales by Region (2021-2026)
  11. 3.4.3 Global Ponatinib Sales by Region (2027-2032)
  12. 3.4.4 Global Ponatinib Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Ponatinib Revenue by Manufacturers
  2. 4.1.1 Global Ponatinib Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Ponatinib Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Ponatinib Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ponatinib Sales by Manufacturers
  6. 4.2.1 Global Ponatinib Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Ponatinib Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Ponatinib Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Ponatinib Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Ponatinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Ponatinib Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Ponatinib Manufacturers, Product Type & Application
  13. 4.7 Global Ponatinib Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Ponatinib Market CR5 and HHI
  16. 4.8.2 2025 Ponatinib Tier 1, Tier 2, and Tier 3
5 Ponatinib Market by Type
  1. 5.1 Global Ponatinib Revenue by Type
  2. 5.1.1 Global Ponatinib Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Ponatinib Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Ponatinib Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Ponatinib Sales by Type
  6. 5.2.1 Global Ponatinib Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ponatinib Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Ponatinib Sales Market Share by Type (2021-2032)
  9. 5.3 Global Ponatinib Price by Type
6 Ponatinib Market by Application
  1. 6.1 Global Ponatinib Revenue by Application
  2. 6.1.1 Global Ponatinib Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Ponatinib Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Ponatinib Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Ponatinib Sales by Application
  6. 6.2.1 Global Ponatinib Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Ponatinib Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Ponatinib Sales Market Share by Application (2021-2032)
  9. 6.3 Global Ponatinib Price by Application
7 Company Profiles
  1. 7.1 ARIAD Pharmaceuticals
  2. 7.1.1 ARIAD Pharmaceuticals Company Information
  3. 7.1.2 ARIAD Pharmaceuticals Business Overview
  4. 7.1.3 ARIAD Pharmaceuticals Ponatinib Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 ARIAD Pharmaceuticals Ponatinib Product Portfolio
  6. 7.1.5 ARIAD Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Ponatinib Market Size by Type
  2. 8.1.1 North America Ponatinib Revenue by Type (2021-2032)
  3. 8.1.2 North America Ponatinib Sales by Type (2021-2032)
  4. 8.1.3 North America Ponatinib Price by Type (2021-2032)
  5. 8.2 North America Ponatinib Market Size by Application
  6. 8.2.1 North America Ponatinib Revenue by Application (2021-2032)
  7. 8.2.2 North America Ponatinib Sales by Application (2021-2032)
  8. 8.2.3 North America Ponatinib Price by Application (2021-2032)
  9. 8.3 North America Ponatinib Market Size by Country
  10. 8.3.1 North America Ponatinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Ponatinib Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Ponatinib Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Ponatinib Market Size by Type
  2. 9.1.1 Europe Ponatinib Revenue by Type (2021-2032)
  3. 9.1.2 Europe Ponatinib Sales by Type (2021-2032)
  4. 9.1.3 Europe Ponatinib Price by Type (2021-2032)
  5. 9.2 Europe Ponatinib Market Size by Application
  6. 9.2.1 Europe Ponatinib Revenue by Application (2021-2032)
  7. 9.2.2 Europe Ponatinib Sales by Application (2021-2032)
  8. 9.2.3 Europe Ponatinib Price by Application (2021-2032)
  9. 9.3 Europe Ponatinib Market Size by Country
  10. 9.3.1 Europe Ponatinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Ponatinib Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Ponatinib Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Ponatinib Market Size by Type
  2. 10.1.1 China Ponatinib Revenue by Type (2021-2032)
  3. 10.1.2 China Ponatinib Sales by Type (2021-2032)
  4. 10.1.3 China Ponatinib Price by Type (2021-2032)
  5. 10.2 China Ponatinib Market Size by Application
  6. 10.2.1 China Ponatinib Revenue by Application (2021-2032)
  7. 10.2.2 China Ponatinib Sales by Application (2021-2032)
  8. 10.2.3 China Ponatinib Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ponatinib Market Size by Type
  2. 11.1.1 Asia Ponatinib Revenue by Type (2021-2032)
  3. 11.1.2 Asia Ponatinib Sales by Type (2021-2032)
  4. 11.1.3 Asia Ponatinib Price by Type (2021-2032)
  5. 11.2 Asia Ponatinib Market Size by Application
  6. 11.2.1 Asia Ponatinib Revenue by Application (2021-2032)
  7. 11.2.2 Asia Ponatinib Sales by Application (2021-2032)
  8. 11.2.3 Asia Ponatinib Price by Application (2021-2032)
  9. 11.3 Asia Ponatinib Market Size by Country
  10. 11.3.1 Asia Ponatinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Ponatinib Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Ponatinib Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ponatinib Market Size by Type
  2. 12.1.1 SAMEA Ponatinib Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Ponatinib Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Ponatinib Price by Type (2021-2032)
  5. 12.2 SAMEA Ponatinib Market Size by Application
  6. 12.2.1 SAMEA Ponatinib Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Ponatinib Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Ponatinib Price by Application (2021-2032)
  9. 12.3 SAMEA Ponatinib Market Size by Country
  10. 12.3.1 SAMEA Ponatinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Ponatinib Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Ponatinib Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Ponatinib Value Chain Analysis
  2. 13.1.1 Ponatinib Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Ponatinib Production Mode & Process
  6. 13.2 Ponatinib Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Ponatinib Distributors
  9. 13.2.3 Ponatinib Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst